SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-13-091618
Filing Date
2013-12-20
Accepted
2013-12-20 17:08:06
Documents
5
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a13-24801_110q.htm 10-Q 822293
2 EX-31.1 a13-24801_1ex31d1.htm EX-31.1 12219
3 EX-31.2 a13-24801_1ex31d2.htm EX-31.2 12186
4 EX-32.1 a13-24801_1ex32d1.htm EX-32.1 6052
5 EX-32.2 a13-24801_1ex32d2.htm EX-32.2 6061
  Complete submission text file 0001104659-13-091618.txt   859773
Mailing Address 2 MERCER ROAD NATICK MA 01760
Business Address 2 MERCER ROAD NATICK MA 01760 508-975-4820
Karyopharm Therapeutics Inc. (Filer) CIK: 0001503802 (see all company filings)

IRS No.: 263931704 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36167 | Film No.: 131292284
SIC: 2834 Pharmaceutical Preparations